Burosumab

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 322 publications

Efficacy and safety of Burosumab in tumor-induced osteomalacia: A systematic review and meta-analysis.

Efficacy and safety of Burosumab in tumor-induced osteomalacia: A systematic review and meta-analysis.

Journal: Bone
Published: February 01, 2026

Metabolic bone diseases : what's new in 2025

Metabolic bone diseases : what's new in 2025

Journal: Revue medicale suisse
Published: January 22, 2026

A phase 2 trial of burosumab for treatment of fibroblast growth factor-23 mediated hypophosphatemia in children and adults with fibrous dysplasia.

A phase 2 trial of burosumab for treatment of fibroblast growth factor-23 mediated hypophosphatemia in children and adults with fibrous dysplasia.

Journal: medRxiv : the preprint server for health sciences
Published: January 02, 2026

Treatment of Fibroblast Growth Factor-23-Mediated Renal Phosphate Wasting With Burosumab in a Patient With Chronic Kidney Disease 3b: A Case Report.

Treatment of Fibroblast Growth Factor-23-Mediated Renal Phosphate Wasting With Burosumab in a Patient With Chronic Kidney Disease 3b: A Case Report.

Journal: Cureus
Published: December 22, 2025

Expanding the Autosomal Recessive Hypophosphatemic Rickets Type I Carrier Phenotype and Adult Treatment with Burosumab.

Expanding the Autosomal Recessive Hypophosphatemic Rickets Type I Carrier Phenotype and Adult Treatment with Burosumab.

Journal: Calcified tissue international
Published: December 04, 2025

Early Dental Manifestations and Multidisciplinary Management of X-Linked Hypophosphatemic Rickets in a Pediatric Patient: A Case Report.

Early Dental Manifestations and Multidisciplinary Management of X-Linked Hypophosphatemic Rickets in a Pediatric Patient: A Case Report.

Journal: Children (Basel, Switzerland)
Published: November 27, 2025

Real-world Impact of Treatment on Growth in Children With X-Linked Hypophosphatemia.

Real-world Impact of Treatment on Growth in Children With X-Linked Hypophosphatemia.

Journal: The Journal of clinical endocrinology and metabolism
Published: November 25, 2025

Comparison of traditional and new treatments for fibrous dysplasia: a systematic review and meta-analysis.

Comparison of traditional and new treatments for fibrous dysplasia: a systematic review and meta-analysis.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: November 18, 2025

Clinical features of Italian adult individuals with X-linked hypophosphatemia: a multicenter retrospective study.

Clinical features of Italian adult individuals with X-linked hypophosphatemia: a multicenter retrospective study.

Journal: Endocrine connections
Published: November 03, 2025

Autoimmune osteomalacia: a novel FGF23-related hypophosphatemic osteomalacia.

Autoimmune osteomalacia: a novel FGF23-related hypophosphatemic osteomalacia.

Journal: Journal of bone and mineral metabolism
Published: November 03, 2025

X-linked hypophosphatemia in the presence of a CLDN16 variant: implications for renal handling and disease severity.

X-linked hypophosphatemia in the presence of a CLDN16 variant: implications for renal handling and disease severity.

Journal: JCEM case reports
Published: October 28, 2025

Global perspectives on the burden and management of hypophosphataemic osteomalacia in adult patients: an International Osteoporosis Foundation (IOF) survey.

Global perspectives on the burden and management of hypophosphataemic osteomalacia in adult patients: an International Osteoporosis Foundation (IOF) survey.

Journal: Archives of osteoporosis
Published: October 24, 2025
Showing 1-12 of 322

Last Updated: 04/28/2026